Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption

47Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Prostate-specific membrane antigen (PSMA), an established enzyme-biomarker for prostate cancer, has attracted considerable attention as a target for imaging and therapeutic applications. We aimed to determine the effects of PSMA-targeted photodynamic therapy (PDT) on cytoskeletal networks in prostate cancer cells. PSMA-targeted PDT resulted in rapid disruption of microtubules (α-/β-tubulin), microfilaments (actin), and intermediate filaments (cytokeratin 8/18) in the cytoplasm of LNCaP cells. The collapse of cytoplasmic microtubules and the later nuclear translocation of α-/β-tubulin were the most dramatic alternation. It is likely that these early changes of cytoskeletal networks are partly involved in the initiation of cell death. © 2010 Elsevier Ireland Ltd.

Cite

CITATION STYLE

APA

Liu, T., Wu, L. Y., & Berkman, C. E. (2010). Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption. Cancer Letters, 296(1), 106–112. https://doi.org/10.1016/j.canlet.2010.04.003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free